5433182026-04-012026-06-305433182026-04-012026-06-30in-capmkt:OtherExpenses1Member5433182026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares543318CLEANNOTLISTEDINE227W01023Clean Science and Technology LimitedMain BoardEquity2026-04-012027-03-312026-08-012026-07-17INRMillionsQuarterlyFirst quarterSingle segmentOrganic chemicals2026-08-0112:30:002026-08-0113:30:00Not applicable2026-04-012026-06-30UnauditedConsolidated2684320000222180000290650000012684800000-219410000166280000520000210470000504650000193099000097551000009755100002130100002900000024201000007335000000000733500000610000734110000000010628000016.96.9006.96.91. The Statement has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34") prescribed under Section 133 of the Companies Act , 2013 read with Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time and the provisions of the Companies Act, 2013 and other accounting principles. <br /> <br /> 2. The above results have been subjected to Limited Review by the statutory auditors of the Company in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and have been reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at its meeting held on August 01, 2026. <br /> <br /> 3. Standalone information: <br /> <br /> Particulars Quarter Ended Year Ended <br /> June 30, 2026 March 31, 2026 June 30, 2025 March 31, 2026 <br /> (Unaudited) (Refer note 6) (Unaudited) (Audited) <br /> <br /> a. Revenue 2,071.04 1,971.30 2,199.06 8,153.35 <br /> b. Profit before tax 975.23 773.90 1,024.15 3,356.11 <br /> c. Profit for the period / year 732.91 581.21 765.74 2,512.17 <br /> d. Other comprehensive income 0.60 1.44 0.03 2.18 <br /> e. Total comprehensive income 733.51 582.65 765.77 2,514.35 <br /> <br /> <br /> 4. The Group is exclusively engaged in the business of manufacturing of organic chemicals. This in the context of the Ind AS 108 Operating Segments, is considered to constitute one single primary segment. <br /> <br /> 5. During the quarter ended June 30, 2026, 5,221 equity shares of Rs. 1/- each fully paid-up, were allotted upon exercise of the vested stock options pursuant to the Company's Employee Stock Option Scheme, 2021 (ESOP 2021). <br /> <br /> 6. The figures for the quarter ended March 31, 2026 as reported in these financial results, are the balancing figures between the audited figures for the year ended March 31, 2026 and unaudited figures for the nine months ended December 31, 2025 which were subjected to limited review. <br /> <br /> 7. During the previous quarter ended March 31, 2026, the Executive Directors voluntarily elected to forgo a substantial portion of their performance bonus entitlement for the financial year 2025-26. Accordingly, the provision for performance bonus recognised in the earlier quarters of the previous year had been reversed to that extent, resulting in lower employee benefits expense for the quarter ended March 31, 2026 as compared to current quarter ended June 30, 2026. <br /> <br /> 8. Clean-Fino Chem Limited (the “Subsidiary”), has entered into an agreement on July 16, 2026 for a long-term strategic collaboration with Geneus Chem AG, a company incorporated under the laws of Switzerland. The agreement is for manufacturing and supply of advanced grades of HALS Products on a worldwide ‘exclusive basis’ and includes, inter alia, provisions relating to minimum offtake commitments and pricing mechanism. In lieu of above collaboration, Geneus Chem AG has agreed to issue warrants to the Subsidiary which are exercisable within a period of four years from the date of issue. Upon exercise of the share warrants, the Subsidiary will acquire 25% of the share capital of Geneus Chem AG on a fully diluted basis and will be required to pay a nominal price per company share to Geneus Chem AG. <br /> <br /> 9. The consolidated results of the Group are available on the Company's website, www.cleanscience.co.in and also on the website of the BSE Limited, www.bseindia.com and National Stock Exchange of India Limited, www.nseindia.com, where the shares of the Company are listed.Other Expenses504650000Remeasurements of post employment benefit obigations810000810000200000610000